Traws Pharma, Inc. — Director's Dealing 2013

Jul 25, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-07-24

Reporting Person: Bienen Henry S (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series I Convertible Preferred Stock	$		Common Stock (9156)		Direct
Stock Option (right to purchase)	$5.76	2019-01-02	Common Stock (4576)		Direct
Stock Option (right to purchase)	$5.76	2019-01-17	Common Stock (375)		Direct
Stock Option (right to purchase)	$5.76	2020-01-02	Common Stock (4576)		Direct
Stock Option (right to purchase)	$5.76	2020-01-02	Common Stock (375)		Direct
Stock Option (right to purchase)	$6.13	2021-01-01	Common Stock (4576)		Direct
Stock Option (right to purchase)	$6.13	2022-01-01	Common Stock (4726)		Direct
Stock Option (right to purchase)	$6.13	2022-01-26	Common Stock (412)		Direct
Stock Option (right to purchase)	$6.13	2022-02-01	Common Stock (412)		Direct
Stock Option (right to purchase)	$7.53	2022-06-22	Common Stock (412)		Direct
Stock Option (right to purchase)	$7.53	2022-07-04	Common Stock (412)		Direct
Stock Option (right to purchase)	$13.28	2022-10-04	Common Stock (412)		Direct
Stock Option (right to purchase)	$13.28	2022-12-18	Common Stock (412)		Direct
Stock Option (right to purchase)	$13.28	2023-01-02	Common Stock (5026)		Direct
Stock Option (right to purchase)	$13.28	2023-01-02	Common Stock (7501)		Direct
Stock Option (right to purchase)	$13.28	2023-02-02	Common Stock (450)		Direct
Stock Option (right to purchase)	$13.28	2023-03-15	Common Stock (450)		Direct
Stock Option (right to purchase)	$14.74	2023-04-23	Common Stock (450)		Direct
Stock Option (right to purchase)	$14.74	2023-04-27	Common Stock (450)		Direct
Stock Option (right to purchase)	$14.74	2023-06-08	Common Stock (450)		Direct
Stock Option (right to purchase)	$14.74	2023-06-12	Common Stock (450)		Direct
Stock Option (right to purchase)	$14.74	2023-06-18	Common Stock (450)		Direct

Footnotes

F1: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.75-for-1 basis and has no expiration date.